Jo Craig
Jo Craig Senior Vice President CMC Jo Craig is Senior Vice President CMC for NeRRe Therapeutics and uses her extensive experience, expertise and leadership to ensure delivery of the chemistry, [...]
Jo Craig Senior Vice President CMC Jo Craig is Senior Vice President CMC for NeRRe Therapeutics and uses her extensive experience, expertise and leadership to ensure delivery of the chemistry, [...]
Rebecca Hemsley Chief Financial Officer Becky is an experienced finance executive with extensive commercial experience. She has held senior finance and operations roles in VC backed, growing [...]
Susan Seymore Vice President of Clinical Operations Susan has 18 years’ experience in the pharmaceutical industry, working within Clinical Operations and Clinical Development. Susan started her [...]
Dr Steve Pawsey Chief Medical Officer Steve Pawsey joined NeRRe Therapeutics as Chief Medical Officer in January 2017. An anaesthetist by training, Steve has extensive experience in the global [...]
Dr Mike Trower Founder & Chief Scientific Officer Mike is a Founder and Chief Scientific Officer of NeRRe, who recognised and championed the belief that next generation neurokinin-1 receptor [...]
Dr Mary Kerr Chief Executive Officer Mary Kerr is CEO of NeRRe Therapeutics. She was Co-Founder and CEO of KaNDy Therapeutics until the company was acquired by Bayer in September 2020 for an [...]
NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.